December 18, 2017 / 7:10 AM / 6 months ago

BRIEF-Sensorion And Cochlear Announce Collaboration To Study Combination Therapies For Cochlear Implant Patients

Dec 18 (Reuters) - SENSORION SA:

* SENSORION AND COCHLEAR ANNOUNCE COLLABORATION TO STUDY COMBINATION THERAPIES FOR COCHLEAR IMPLANT PATIENTS

* ‍WILL EVALUATE SENS-401 IN COMBINATION WITH COCHLEAR’S COCHLEAR IMPLANTS IN PRECLINICAL SETTING IN 2018​

* ‍COCHLEAR WILL INVEST AROUND EUR 1.6 MILLION AND RECEIVE AN EQUITY STAKE IN SENSORION​

* COCHLEAR WILL RECEIVE A RIGHT OF FIRST NEGOTIATION FOR SENS-401 GLOBAL USE IN COMBINATION WITH CERTAIN IMPLANTABLE DEVICES

* ‍POTENTIAL MID-STAGE CLINICAL TESTING TO BEGIN AS SOON AS 2019​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below